News Alert

Merck Extends its Conditions on 340B Pricing Involving Contract Pharmacies to Health Centers

Merck exterior building sign
Merck extended its restrictions on 340B pricing involving contract pharmacies to community health centers.

Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers. The restrictions have applied only to hospital covered entities until now.

Other grantee covered entities remain exempt “at this time,” Merck said, adding

Read More »

340B Report Holding May 18 Webinar on Implementing Drug Makers’ New 340B Contract Pharmacy Rules

customers in line at a pharmacy
Multiple 340B covered entities and consultants say they have hit roadblocks trying to navigate drug manufacturers restrictions on 340B pricing when entities contract with outside pharmacies to dispense 340B drugs.

340B Report, an independent news organization covering the 340B drug pricing program, is holding its first event—a May 18 webinar about implementing drug manufacturers’ controversial new rules on 340B contract pharmacies. It is an exclusive and free

Read More »

Providers Alarmed About 45-Day Lookback Clauses in Drug Makers’ 340B Contract Pharmacy Policies

closeup of sand in an hourglass
Covered entities are concerned about 45-day time limits for claims submissions and replenishment orders in drug manufacturers' 340B contract pharmacy policies.

Drug manufacturer Sanofi drew attention this month when it added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.

Pfizer and Amgen also recently added similar 45-day lookback requirements

Read More »

How 340B Works for People Living with HIV

Asha Doucet headshot on light blue background

SPONSORED CONTENT

At AIDS Healthcare Foundation, we commit to linking any person newly diagnosed with HIV to care within 72 hours of their reactive result. In addition, through our AHF Wellness Centers that offer free STI (Sexually Transmitted Infection) screening and testing, our Healthcare Centers, our Mobile Testing Units,

Read More »

HIV/AIDS Clinics Tell FTC that PBMs Usurp 340B Discounts for Themselves

sculpture of a man and horse outside a federal building
The "Man Controlling Trade" statute outside the FTC's Washington, D.C., headquarters. HIV/AIDS clinics recently submitted comments to the commission about PBMs' business practices.

Pharmacy benefit managers (PBMs) should be stopped from usurping 340B drug discounts from HIV/AIDS clinics and other safety-net providers, Ryan White Clinics for 340B Access (RWC-340B) told the U.S. Federal Trade Commission (FTC) last week.

RWC-340B asked the commission for

Read More »

With Retired Sen. Hatch’s Passing, a Legendary 340B Tale is Told

Sen. Orrin Hatch headshot
Retired U.S. Sen. Orrin Hatch (R-Utah), who died this weekend, played a key role in 340B's creation and development.

Retired U.S. Sen. Orrin Hatch of Utah, a conservative Republican icon who helped create and shape the 340B drug pricing program, has died. He was 88.

Hatch personally was responsible for choosing one of the 340B program’s most important covered

Read More »

Federal Circuit Court Begins Lilly’s 340B Contract Pharmacy Lawsuit Appeal in Earnest

Courtroom interior of the USCA Seventh Circuit
The U.S. Seventh Circuit Court of Appeals issued a schedule for the filing of briefs in Lilly's 340B contract pharmacy lawsuit.

A federal appeals court in Chicago is satisfied with the final judgement it ordered a lower court to issue in Lilly’s 340B contract pharmacy lawsuit, clearing the way the lawsuit’s next stage to get rolling.

The U.S. Seventh Court of

Read More »

Influential HIV/AIDS Group Asks Gilead to Exempt Ryan White Clinics from Company’s 340B Contract Pharmacy Restrictions

Gilead exterior office sign
Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies wholly owned by covered entities.

Ryan White Clinics for 340B Access (RWC-340B) has asked drug manufacturer Gilead to exempt all Ryan White clinics from the company’s conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

RWC-340B made the

Read More »

73 Groups Want Congress to Enact Major Drug Pricing Reforms by Memorial Day

Push for Lower Rx Prices organization wordmark
Seventy three organizations, under the banner Push for LowerRx Prices, launched a campaign to press Congress to pass comprehensive Democratic drug pricing legislation by Memorial Day.

More than 70 groups representing patients, healthcare professionals, consumers, retirees, employers, and unions launched a campaign this morning to get comprehensive Democratic drug pricing legislation signed into law by Memorial Day.

It is premature to guess how the final version

Read More »

Six Groups Slam Drug Makers’ 340B Pricing Conditions on Hepatitis C Medicines

Six HIV/AIDS and viral hepatitis advocacy groups issued a joint statement criticizing AbbVie, Gilead, and Merck’s conditions on 340B pricing on hepatitis C medications.

UPDATE Thursday, April 21, 2022, 5:00 p.m. EDT—AbbVie issued this statement: AbbVie supports the 340B program and is committed to the program’s goal of improving access to medicines for uninsured and vulnerable patients. Our 340B initiative does not block access

Read More »